AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Avoiding deceptive imprinting in AIDS vaccine development reviewed.

Vaccine Weekly

| December 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists outline methods to avoid deceptive imprinting of the immune response to HIV-1 infection in vaccine development in a recent issue of International Reviews of Immunology.

According to a study from the United States, "Lymphocyte clonal restriction is caused by priming the immune system with an antigen and has been referred to infectious disease study as 'original antigenic sin' (OAS), described first for influenza by Francis. OAS is a dominant feature of a normal immune response. Benefits of OAS come from the initial contact with the pathogen, which induces immunological memory. Memory is achieved by priming B and T cells of an immunologically naive host, and confers protection against infection with the antigen-related pathogen. Thus, a restricted antibody response to viral or parasite antigens is not per se pathogenic."

"However, the interplay between a 'locked-in' immune response and the high genetic variation of the pathogenic agent can result in a deception of the immune system," said Sybille Muller at Immpheron Inc. "In the following, clonal restriction of the immune response to HIV is described by ...

Related articles from newspapers, magazines, journals, and more
'India's vaccine development sector to lead biopharma biz'.
News wire article from: PTI - The Press Trust of India Ltd. December 27, 2005 700+ words
'India's vaccine development sector to lead biopharma biz...India as the future site for vaccine development," a study undertaken by...favourite destination for vaccine development," he said. "It's a win...
Thailand announces breakthrough in HIV vaccine development
News wire article from: Xinhua News Agency September 24, 2009 700+ words
...Thailand announces breakthrough in HIV vaccine development BANGKOK, Sept. 24 (Xinhua...announced the breakthrough in the HIV vaccine development -- the first time ever that there...important foundation for further HIV vaccine development in Thailand in the future," said...
International Scientific Conference Features Advances in Vaccine Development...
Press release article from: Business Wire September 22, 2008 700+ words
...the inherent problems in existing vaccine development technologies," Dr. Yusibov said...of the success and viability of a vaccine development project is the choice of an appropriate...sessions covering new substrates for vaccine development through clinical trial case studies...
Novavax Acquires Vaccine Development Division of DynCorp.
Press release article from: PR Newswire August 11, 1999 700+ words
...Division's 45-Year Expertise in Vaccine Development and Manufacture to Develop Therapies...Division's extensive expertise in vaccine development and manufacturing to develop therapies...technology with the Division's vaccine development and manufacturing capabilities...
IAVI Applauds Historic UN Security Council Session on AIDS in Africa; Calls...
Press release article from: PR Newswire January 10, 2000 700+ words
...biotech industries to engage in vaccine development." "Smallpox was eradicated thanks...to expand its commitment to AIDS vaccine development and ultimate distribution. Without...IAVI's scientific program is the Vaccine Development Partnership, a collaborative model...
AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support.
Newspaper article from: Heart Disease Weekly June 14, 2009 700+ words
The atherosclerosis vaccine development program by AFFiRiS AG is receiving...announced by AFFiRiS AG (see also Vaccine Development). Vienna-based AFFiRiS...announced that its atherosclerosis vaccine development program is receiving support...
ID Biomedical Corp.: Senior Vaccine Development Scientist, Dr. Mark Reddish,...
Press release article from: Business Wire January 14, 1998 700+ words
...Corporation. His experience includes vaccine development from basic research through preclinical...quality of the company's preclinical vaccine development programs and its R and D team...scientific articles and abstracts on vaccine development. He is an often invited speaker...
Jerald Sadoff M.D. Named CEO of TB Vaccine Effort; Aeras Global TB Vaccine...
Press release article from: PR Newswire September 17, 2003 700+ words
...the former Clinical Director for Vaccine Development at Merck, as its new Chief Executive...announced a new scientific focus on TB vaccine development. This will leave the development...job done." Sadoff said the Aeras vaccine development efforts will be integrated with...
For more facts and information, see all results

Source: HighBeam Research, Avoiding deceptive imprinting in AIDS vaccine development reviewed.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA